<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04557254</url>
  </required_header>
  <id_info>
    <org_study_id>STAGER Study</org_study_id>
    <nct_id>NCT04557254</nct_id>
  </id_info>
  <brief_title>Silver Acetate and Triclosan Antimicrobial Graft Evaluation for Surgical Repair of Aortic Disease</brief_title>
  <official_title>A Retrospective Single-center Comparative Analysis of Early and Long-term Results of Aortic Surgical Replacement Using Silver Acetate and Triclosan Impregnated Antimicrobial Grafts Versus Standard Dacron Vascular Grafts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The number of surgical and endovascular aortic repairs is continuously increasing, and&#xD;
      infective graft complications are observed more frequently. (1) Several etiopathogenetic&#xD;
      factors may play a role in aortic prosthetic infections, including hematogenous seeding,&#xD;
      local bacterial translocation, and iatrogenous contamination. Infectious graft complications&#xD;
      represent a critical event requiring a multidisciplinary management. Knowledge on underlying&#xD;
      microorganisms, antibiotic efficacy, risk factors, and prevention strategies has a key role&#xD;
      in the management of this spectrum of infectious diseases involving the aorta.&#xD;
&#xD;
      the aim of the study is evaluate the early and long-term clinical results, up to 5 years&#xD;
      (through follow-up outpatient visits), of a silver and triclosan knitted collagen coated&#xD;
      polyester vascular graft (InterGard Synergy), in patients submitted to aortic surgical&#xD;
      repair, and compare them with concurrent results of standard Dacron grafts. Results will be&#xD;
      reported and analyzed according to the type of aortic disease requiring surgical repair.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 25, 2020</start_date>
  <completion_date type="Actual">September 15, 2021</completion_date>
  <primary_completion_date type="Actual">August 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients without infectious complications</measure>
    <time_frame>30 days</time_frame>
    <description>freedom from infectious complications (percentage)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients without infectious complications</measure>
    <time_frame>5 years</time_frame>
    <description>freedom from infectious complications (percentage)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Infective Graft Complications</condition>
  <arm_group>
    <arm_group_label>silver-triclosan graft implantation (SynG group)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>standard Dacron graft implantation (DacrG group)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>graft</intervention_name>
    <description>evaluate the early and long-term clinical results, up to 5 years (through follow-up outpatient visits), of a silver and triclosan knitted collagen coated polyester vascular graft (InterGard Synergy), in patients submitted to aortic surgical repair, and compare them with concurrent results of standard Dacron grafts.</description>
    <arm_group_label>silver-triclosan graft implantation (SynG group)</arm_group_label>
    <arm_group_label>standard Dacron graft implantation (DacrG group)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who have surgery aortic repair in which it was used a prosthesis containing&#xD;
        antimicrobial agents or a standard vascular prosthesis (Dacron)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        • Patients submitted to aortic surgical repair (elective or emergent) with a silver and&#xD;
        triclosan knitted collagen coated polyester vascular graft or standard Dacron grafts, for&#xD;
        different aortic pathologies at the Division of Vascular Surgery, San Raffaele Scientific&#xD;
        Institute, between 2012 and 2019&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        • not present&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IRCCS San Raffaele Hospital</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Berard X, Stecken L, Pinaquy JB, Cazanave C, Puges M, Pereyre S, Bordenave L, M'Zali F. Comparison of the Antimicrobial Properties of Silver Impregnated Vascular Grafts with and without Triclosan. Eur J Vasc Endovasc Surg. 2016 Feb;51(2):285-92. doi: 10.1016/j.ejvs.2015.10.016. Epub 2015 Dec 9.</citation>
    <PMID>26680451</PMID>
  </reference>
  <results_reference>
    <citation>Kahlberg A, Melissano G, Tshomba Y, Leopardi M, Chiesa R. Strategies to treat thoracic aortitis and infected aortic grafts. J Cardiovasc Surg (Torino). 2015 Apr;56(2):269-80. Epub 2015 Jan 22. Review.</citation>
    <PMID>25608572</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 8, 2020</study_first_submitted>
  <study_first_submitted_qc>September 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2020</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Prof. Andrea Kahlberg</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

